These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12952733)

  • 41. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy.
    Metzner KJ; Rauch P; von Wyl V; Leemann C; Grube C; Kuster H; Böni J; Weber R; Günthard HF
    J Infect Dis; 2010 Apr; 201(7):1063-71. PubMed ID: 20196655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals.
    James CW; Moffett LE; Szabo S
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
    Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
    Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
    Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recovery and analysis of human immunodeficiency virus type 1 (HIV) RNA sequences from plasma samples with low HIV RNA levels.
    Niubò J; Li W; Henry K; Erice A
    J Clin Microbiol; 2000 Jan; 38(1):309-12. PubMed ID: 10618106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R; Figueiredo S; Bártolo I; Pinheiro M; Rosado L; Soares I; Lourenço H; Taveira N
    J Clin Microbiol; 2003 Jul; 41(7):3361-7. PubMed ID: 12843094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance.
    Gleaves CA; Welle J; Campbell M; Elbeik T; Ng V; Taylor PE; Kuramoto K; Aceituno S; Lewalski E; Joppa B; Sawyer L; Schaper C; McNairn D; Quinn T
    J Clin Virol; 2002 Aug; 25(2):205-16. PubMed ID: 12367656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of pooled viral load testing to identify antiretroviral treatment failure.
    Smith DM; May SJ; Pérez-Santiago J; Strain MC; Ignacio CC; Haubrich RH; Richman DD; Benson CA; Little SJ
    AIDS; 2009 Oct; 23(16):2151-8. PubMed ID: 19730348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
    Baumeister MA; Zhang N; Beas H; Brooks JR; Canchola JA; Cosenza C; Kleshik F; Rampersad V; Surtihadi J; Battersby TR
    PLoS One; 2012; 7(3):e33295. PubMed ID: 22479381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits.
    Chernoff DN
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):134-40. PubMed ID: 12942672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An affordable HIV-1 drug resistance monitoring method for resource limited settings.
    Manasa J; Danaviah S; Pillay S; Padayachee P; Mthiyane H; Mkhize C; Lessells RJ; Seebregts C; de Wit TF; Viljoen J; Katzenstein D; De Oliveira T
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of resistance mutations preceding virologic failure in patients receiving antiretroviral therapy.
    Diaz RS; Accetturi CA; Sucupira MC
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):111-3. PubMed ID: 18725808
    [No Abstract]   [Full Text] [Related]  

  • 59. Reproducibility and performance of the second-generation branched-DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Gonin P; Fauvel M
    J Clin Microbiol; 1999 Mar; 37(3):812-4. PubMed ID: 9986862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring HIV viral loads in the United States: recent trends and methodologies.
    Peter JB; Blum RA
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):261-2. PubMed ID: 12045692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.